Ophthotech Raises $30 Million
Ophthotech Corp., a Princeton, N.J.-based developer of ophthalmic therapies for both wet and dry age-related macular degeneration, has raised $30 million in Series B funding. Clarus Ventures led the round, and was joined by return backers SV Life Sciences, Novo A/S and HBM BioVentures. The company has now raised over $100 million.
15 December 2009•3 mins read
